Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Coloplast A/S
Age
25–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Has an estimated life expectancy of more than 5 years
Has been diagnosed with erectile dysfunction
Is willing to have the Titan IPP implanted
Is able and willing to complete all follow-up visits and procedures indicated in this protocol
Has been informed of the nature of the study and agrees to its provisions and - Has provided written informed consent as approved by the Institutional Review board of the respective site
You may not be if
Participant has had a previous penile prosthesis or prior penile enlargement surgeries
Participant has a compromised immune system
Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment
Participant does not have manual dexterity or mental ability to operate the pump
Participant has an active urogenital infection or active skin infection in region of surgery
Participant is diagnosed with fibrotic disease, such as priapism or Peyronie's disease
Participant is diagnosed with Chordee
Participant has neuropathy
Participant has a serious bleeding disorder or coagulopathy
Clareo Health | Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)
